How synthetic binders are transforming diagnostics and molecular biology

Thursday, May 7 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT

Traditional antibodies often fall short when precision and reliability matter most. In this SelectScience® webinar, held in partnership with Aptamer Group, we will showcase how synthetic binders are delivering breakthrough results where antibodies have failed.

Hear directly from Alphazyme on how Optimer® technology revolutionized their hot-start PCR applications, replacing two antibodies with a single, more effective solution. Discover how Neuro-Bio achieved unprecedented sensitivity in developing a groundbreaking Alzheimer's test targeting a new biomarker, after struggling with traditional antibody approaches.

Register now to join leading scientists as they share real data, practical insights, and lessons learned from moving beyond antibodies. Whether you're developing diagnostics, optimizing molecular biology workflows, or seeking more reliable research tools, this session will demonstrate proven alternatives that are transforming detection and diagnostics.

Key learning objectives:

  • Discover proven alternatives for challenging targets
  • See real-world case studies where Optimer® technology succeeded in hot-start PCR optimisation and sensitive biomarker detection after antibodies fell short
  • Understand the technical advantages (batch consistency, stability, specificity) and assess whether this technology could solve your current reagent challenges
  • Evaluate when alternative binding technologies might address similar challenges in your own research or diagnostic development projects
  • Learn how new biomarkers for Alzheimer’s disease are opening potential for early detection, plus insights into developing sensitive assays for novel diagnostic targets
  • See how tailored enzyme control mechanisms are helping scientists achieve better specificity and reliability in hot-start PCR and NGS workflows

Who should attend?

This webinar is ideal for:

  • Diagnostic developers and assay scientists seeking reliable reagents for challenging targets or looking to improve assay performance and consistency
  • Molecular biologists and PCR specialists working with enzyme optimization, hot-start applications, or experiencing variability in amplification results
  • Biomarker researchers and clinical scientists developing tests for neurodegenerative diseases, early disease detection, or novel diagnostic targets
  • R&D professionals in pharma and biotech evaluating reagent alternatives for drug development, clinical trials, or companion diagnostics
  • Laboratory managers and procurement teams responsible for selecting critical reagents and addressing supply chain or performance issues

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.

Speakers

Eglė Kybartaitė
Eglė Kybartaitė
Speaker
Staff Product Manager, Alphazyme, part of Maravai LifeSciences
See more
Baroness Susan Greenfield
Baroness Susan Greenfield
Speaker
Chief Executive Officer, Neuro-Bio
See more
Dr. David Bunka
Dr. David Bunka
Speaker
Chief Scientific Officer, Aptamer Group
See more
Matilde Marques
Matilde Marques
Moderator
Assistant Editor, SelectScience

Links

Tags

Register for free